Hatteras Venture Advisors III LLC 13D and 13G filings for Clearside Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-04 4:15 pm Sale |
2022-12-15 | 13D | Clearside Biomedical, Inc. CLSD |
Hatteras Venture Advisors III LLC | 3,654,062 6.100% |
-1,360,858 (-27.14%) |
Filing |